Tech Moves

Tech Strikes: Adaptive Biotechnologies’ chief medical officer resigns; Athira Pharma’s new hires

Lance Baldo. (Adaptive Photograph)

Lance Baldo stepped down as chief medical officer of Adaptive Biotechnologies. Baldo is “transferring on to pursue one other skilled alternative within the early most cancers screening market near residence,” a spokesperson for the Seattle firm instructed GeekWire. The doctor and former head of U.S. medical affairs at Genentech has been primarily based out of South San Francisco and joined publicly traded Adaptive in 2019.

The transfer comes after Adaptive laid off 12% of its workforce, about 100 staff, in early March. The corporate additionally introduced a brand new CFO, Tycho Peterson, and narrowed its focus to 2 key enterprise areas, immune medication and detection of minimal residual illness (MRD) in oncology.

The medical crew now experiences to Sharon Benzeno, chief industrial officer for immune medication, and Nitin Sood, chief industrial officer for MRD. Benzeno was beforehand a company-wide chief enterprise improvement officer and Sood was chief industrial officer.

Adaptive’s partnership with South San Francisco-based Genentech to develop T-cell primarily based mobile therapies will proceed.

— Athira Pharma introduced new hires and promotions. Josh Pan was promoted to VP of company improvement and Robert Renninger to VP of finance and accounting. The corporate employed Simon Daggett as VP of medical operations; he was beforehand head of medical operation at Bioniz Therapeutics and was director of medical improvement at Allergan. The corporate additionally employed Lana Gloukhova as VP of drug security and pharmacovigilance.

Athira has been regrouping after the departure of its long-time CEO and co-founder Leen Kawas this fall, within the wake of an organization investigation into knowledge integrity of scientific papers she co-authored. The corporate expects to announce top-line knowledge subsequent quarter on a section 2 medical trial of its experimental remedy for Alzheimer’s illness and has different ongoing trials.

Related Articles

Trả lời

Email của bạn sẽ không được hiển thị công khai. Các trường bắt buộc được đánh dấu *